Alice Di Rocco | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Out of specification Tisagenlecleucel is associated with outcomes comparable to standard of care product in relapsed or refractory diffuse large B-cell lymphoma	BONE MARROW TRANSPLANTATION	2024
Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study	LEUKEMIA	2024
Outcomes of younger patients with mantle-cell lymphoma experiencing late relapse (>24 months): the LATE-POD study	BLOOD	2024
Secondary primary malignancies after CD-19 directed CAR-T-cell therapy in lymphomas: A report from the Italian CART-SIE study	BRITISH JOURNAL OF HAEMATOLOGY	2024
Whole body MRI with Difusion Weighted Imaging versus 18F‑fuorodeoxyglucose‑PET/CT in the staging of lymphomas	LA RADIOLOGIA MEDICA	2023
Long-Term Host Immune Modulation Following Tisagenlecleucel Administration in Patients with Diffuse Large B-Cell Lymphoma and B-Lineage Acute Lymphoblastic Leukemia	CANCERS	2023
Long term follow-up of Rituximab plus Bendamustine and Cytarabine (R-BAC) in elderly patients with newly diagnosed MCL	BLOOD ADVANCES	2023
Whole body MRI with Diffusion Weighted Imaging versus 18F-fluorodeoxyglucose-PET/CT in the staging of lymphomas	LA RADIOLOGIA MEDICA	2023
Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the FIL MCL0208 trial	BLOOD ADVANCES	2023
Biological features and outcome of diffuse large B-cell lymphoma associated with hepatitis C virus in elderly patients: Results of the prospective 'Elderly Project' by the Fondazione Italiana Linfomi	BRITISH JOURNAL OF HAEMATOLOGY	2023
Management of patients with lymphoma and COVID-19: Narrative review and evidence-based practical recommendations	HEMATOLOGICAL ONCOLOGY	2023
Efficacy of Residual Site Radiation Therapy (ISRT) in Patients with Primary Mediastinal Lymphoma with Deauville Score 4 Following R-CHT: Results of a Retrospective Mono Institutional Study	JOURNAL OF CLINICAL MEDICINE	2023
Myelodysplastic clones arising post chimeric antigen receptor t cell therapy (car-t) procedure: a casuality or a new entity?	ANNALS OF HEMATOLOGY	2023
Case Report: Severe cutaneous adverse event associated with checkpoint inhibition in the setting of CAR T-cell therapy: beyond CRS	FRONTIERS IN ONCOLOGY	2023
High prevalence of past hepatitis B virus infection in diffuse large B cell lymphoma: a retrospective study from Italy	ANNALS OF HEMATOLOGY	2023
Impact of SARS-CoV-2 vaccination and passive prophylaxis with tixagevimab/cilgavimab on CAR-T patients: a three-year regional experience from the Italian covid pandemic	BONE MARROW TRANSPLANTATION	2023
Outcome after chimeric antigen receptor (CAR) T-cell therapy failure in large B-cell lymphomas	BRITISH JOURNAL OF HAEMATOLOGY	2023
A Fondazione Italiana Linfomi cohort study of R-COMP vs R-CHOP in older patients with diffuse large B-cell lymphoma	BLOOD ADVANCES	2023
Case Report: Severe cutaneous adverse event associated with checkpoint inhibition in the setting of CAR T-cell therapy: beyond CRS	FRONTIERS IN ONCOLOGY	2023
Bing-Neel syndrome coexisting with oligodendroglioma	LEUKEMIA & LYMPHOMA	2022

Progetti di Ricerca

The impact of different treatment strategies on minimal residual disease (MRD) in young and elderly Mantle cell lymphoma (MCL) patients.
Non invasive monitoring of aggressive lymphomas by next generation sequencing/droplet digital PCR on circulating tumor-DNA (ct-DNA)